Jose Luis Ricón Fernández de la Puente is widely known for his influential blog “Nintil” and in his current role as Head of Theory at Retro Biosciences, a leading company in the longevity biotech space funded with $180m by Sam Altman. Niklas and Jose Luis dive into:

* Why the current scientific institutions often fail to deliver on its promises

* The most promising pathways and bottlenecks in longevity biotech

* Lessons from libertarianism and economics for building better scientific institutions

* The role of network cities, special jurisdictions, and parallel systems

Stranded Technologies Podcast is the channel for the Infinita community, dedicated to accelerating longevity biotech and building the future of innovation-friendly cities.

More about GUEST'S work:

* Retro.bio

* Nintil

Cush is the founder of Odisea Labs, an accelerator for Latin American frontier tech (crypto, AI). Cush is inspired by effective accelerationism (e/acc) and consequently coined the memes “latam/acc” and “Latin American Dynamism” in reference to their US-based counterpart.

In this episode, we learn all about why Latam is awesome for tech. Financial innovation and crypto have a fertile ground here and are widely adopted due the lack of banking access for large populations, regulatory capture and government mismanagement.

Odisea Labs has been a major partner to the past March Startup Residency Month, and is now announcing another partnership with Infinita City for the following:

Crypto Cities Theme Month

This is a one-month program for builders to deploy crypto-native projects, not just online, but in a functioning city with enabling legislation, crypto taxes, and a supportive community.

🗓️ | June 1 - 30, 2025📍 | Próspera Zone, Roatan (Honduras)➡️ | Signup: infinita.city/crypto-cities

Jack Scannell is a consultant, researcher, and entrepreneur. Jack is one of the world’s leading authorities on pharmaceutical R&D productivity. He co-authored the influential 2012 paper in Nature Reviews Drug Discovery that introduced “Eroom’s Law,” a concept highlighting how drug discovery has become slower and more expensive over time—essentially the opposite of Moore’s Law. Scannell has advised major pharmaceutical firms and is a noted commentator on strategies to improve innovation efficiency in the life sciences. He is currently building Ethereos.

Explore Infinita City:

* Explore the Archive: The Infinita City Times

* Visit Infinita City

* Join the Builders’ Hub on Telegram

* Follow Infinita City on X